- ISSN: 0929-8673
- E-ISSN: 1875-533X
-
s Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer
- Source: Current Medicinal Chemistry, Volume 30, Issue 9, Mar 2023, p. 1000 - 1002
-
- 01 Mar 2023
Preview this article:
Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cmc/30/9/s2-1.gif
There is no abstract available.
© Bentham Science Publishers
